Brokerage : Hanwha Investment & Securities Analyst : Yong-wook Lee Investment Rating : Buy (Maintained) Target Price : KRW 350,000 (Lowered) Core Momentum : While 4Q25 results remained soft and EV battery recovery is delayed, commercial NCA ESS shipments from the STLA JV and the planned 2H26 North American LFP ESS startup serve as the…
![[Research] Samsung Biologics (207940) – Kiwoom Securities | Plant 5 H2 Revenue Recognition · US Site Cost Control · 2026 Profitability Defense / 2026-01-07](https://koreaequitylens.com/wp-content/uploads/2026/08/포맷변환삼성바이오로직스.jpg)
Brokerage : Kiwoom Securities Analyst : Hyemin Huh Investment Rating : BUY (Maintained) Target Price : KRW 2,100,000 (Maintained) Core Momentum : Despite near-term raw material inflation and US plant acquisition overhead, 100% capacity utilization across Plants 1–4 and H2 Plant 5 revenue contributions will defend 2026 OPM at 2025 levels. 📊 1. [Valuation &…
Brokerage : Yuanta Securities Analyst : Hyunsoo Ha Investment Rating : BUY (Maintained) Target Price : KRW 2,100,000 (Upgraded) Core Momentum : Full capacity operation across Plants 1–4 combined with the acquisition of the US Maryland facility, continuous contract momentum following the Biosecure Act passage, and modality expansions at Campus 3. 📊 1. [Valuation &…
Brokerage : Hana Securities Analyst : Seona Kim (RA: Changkeun Yoo) Investment Rating : BUY (Maintained) Target Price : KRW 2,050,000 (Upgraded) Core Momentum : Sustained mid-40% OPM post-spinoff and annual orders surpassing KRW 6.8 Trillion, with 2026 JPMHC presentations set to provide visibility on Plant 6 groundbreaking and new modality CAPEX. 📊 1. [Valuation…
Market: KOSPI (000660) Brokerage : Shinhan Securities Analyst : Hyungtae Kim (RA: Hyesus Song) Investment Rating : BUY (Maintained) Target Price : 860,000 KRW (Raised) Core Momentum : Intensifying commodity DRAM supply shortages and low channel inventories are expected to sustain supplier pricing power, while an extended HBM3E cycle and rising ASIC adoption support continued…
Market: KOSPI (000660) Brokerage : Daishin Securities Analyst : Hyeongkeun Ryu (RA: Jiwon Seo) Investment Rating : BUY (Maintained) Target Price : 840,000 KRW (Raised) Core Momentum : HBM4 commercialization and severe commodity memory supply shortages are expected to drive record earnings through the combined strength of HBM and conventional DRAM, while ADR and SPC…
![[Research] LigaChem Biosciences (141080) – IBK Securities | Enhertu Resistance · Clinical Readouts · Tech Transfer / 2025-11-27](https://koreaequitylens.com/wp-content/uploads/2026/08/포맷변환-리가캠바이오.jpg)
Brokerage : IBK Securities Analyst : E-soo Jung, CFA Investment Rating : Not Rated Target Price : – Core Momentum : Demonstration of clinical efficacy in Enhertu-resistant patients and concentrated 1H26 clinical readouts driving subsequent out-licensing deals 📊 1. [Valuation & Key Financial Metrics] 🚀 2. [Market Opportunities & Business Outlook] 📝 Editor’s Comment (Perspective)…
Brokerage : Hanwha Investment & Securities Analyst : Seongjo Bae, RA Now Kim Investment Rating : Buy (Maintain) Target Price : KRW 740,000 (Maintain) Core Momentum : 3Q25 earnings beat driven by domestic production leverage, supported by a KRW 23.4T order backlog and accelerating export recognition (Iraq exports and Cheongung-II) 1. [Valuation & Key Financial…
![[IR] Samsung Electronics (005930) – Q3 2025 Earnings Presentation / 2025-10-30](https://koreaequitylens.com/wp-content/uploads/2026/08/포맷변환삼성전자-IR.jpg)
💡 3-Second Summary Driven by expanding HBM3E sales, rising memory ASPs, and new foldable smartphone launches, Samsung Electronics posted Q3 2025 consolidated revenue of KRW 86.1T and operating profit of KRW 12.2T. Moving forward, the company aims to scale high-value memory including HBM4 and server DDR5/SSDs, while its Foundry division focuses on scaling GAA 2nm…
Read More “[IR] Samsung Electronics (005930) – Q3 2025 Earnings Presentation / 2025-10-30” »
![[IR] Samsung Electro-Mechanics (009150) – Q3 2025 Earnings Presentation / 2025-10-29](https://koreaequitylens.com/wp-content/uploads/2026/08/포맷변환삼성전기-IR.jpg)
💡 3-Second Summary Samsung Electro-Mechanics posted Q3 2025 revenue of KRW 2.8890T and operating profit of KRW 260.3B, with year-over-year sales growth across all business segments, while continuing to expand AI server/automotive supplies and accelerate next-generation product developments in Q4. 📊 1. [Key Guidance & Quantitative Roadmap] 🚀 2. [Business Strategy & Future Plans] 📝…
Read More “[IR] Samsung Electro-Mechanics (009150) – Q3 2025 Earnings Presentation / 2025-10-29” »